abstract |
The present invention relates to a stable pharmaceutical preparation, and more particularly, to a pharmaceutical preparation comprising a binding molecule to the SARS-coronavirus-2 surface spike protein (S protein). The stable pharmaceutical formulation according to the present invention has excellent long-term storage stability under temperature conditions such as accelerated conditions and severe conditions, and can maintain excellent stability even under physical stress conditions such as light, freezing/thawing, and shaking. |